Profile

New User

New to Graphy Publications? Create an account to get started today.

Registered Users

Have an account? Sign in now.

How to Cite | Author Information | Publication History
International Journal of Clinical Research & Trials Volume 5 (2020), Article ID 5:IJCRT-142, 8 pages
https://doi.org/10.15344/2456-8007/2020/142
Review Article
Effects of Stevia Rebaudiana on Glucose Homeostasis, Blood Pressure and Inflammation: A Critical Review of Past and Current Research Evidence

Justina Ray, Shweta Kumar, Daniel Laor, Naila Shereen, Felix Nwamaghinna, Alastair Thomson, Jessica Perez Perez, Lina Soni and Samy I. McFarlane*

Department of Medicine, Division of Endocrinology, SUNY-Downstate Health Science University, 450 Clarkson Avenue, Brooklyn, New York, USA
Prof. Samy I. McFarlane, Division of Endocrinology, Department of Internal Medicine, State University of New York, Downstate Medical Center, Brooklyn, New York,11203, USA, Tel: 718-270-6707, Fax: 718- 270-4488; E-mail: smcfarlane@downstate.edu
28 November 2019; 20 January 2020; 22 January 2020
Ray J, Kumar S, Laor D, Shereen N, Nwamaghinna F, et al. (2020) Effects of Stevia Rebaudiana on Glucose Homeostasis, Blood Pressure and Inflammation: A Critical Review of Past and Current Research Evidence. Int J Clin Res Trials 5: 142. doi: https://doi.org/10.15344/2456-8007/2020/142
© 2020 Ray et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

References

  1. Ashamalla M, Youssef I, Yacoub M, Jayarangaiah A, Gupta N, et al. (2018) Obesity, Diabetes and Gastrointestinal Malignancy: The role of Metformin and other Anti-diabetic Therapy. Glob J Obes Diabetes Metab Syndr 5: 8-14. [CrossRef] [Google Scholar] [PubMed]
  2. Jehan S, Myers AK, Zizi F, Pandi-Perumal SR, Jean-Louis G, et al. (2018) Obesity, obstructive sleep apnea and type 2 diabetes mellitus: Epidemiology and pathophysiologic insights. Sleep Med Disord 2: 52-58. [Google Scholar] [PubMed]
  3. Sharma N, Lee J, Youssef I, Salifu MO, McFarlane SI, et al. (2017) Obesity, Cardiovascular Disease and Sleep Disorders: Insights into the Rising Epidemic. J Sleep Disord Ther 6: 260. [CrossRef] [Google Scholar] [PubMed]
  4. Jehan S, Zizi F, Pandi-Perumal SR, Wall S, Auguste E, et al. (2017) Obstructive Sleep Apnea and Obesity: Implications for Public Health. Sleep Med Disord 1: 19. [Google Scholar] [PubMed]
  5. Forte V, Pandey A, Abdelmessih R, Forte G, Whaley-Connell A, et al. (2012) Obesity, Diabetes, the Cardiorenal Syndrome, and Risk for Cancer. Cardiorenal Med 2: 143-162. [CrossRef] [Google Scholar] [PubMed]
  6. Karam JG, El-Sayegh S, Nessim F, Farag A, McFarlane SI, et al. (2007) Medical management of obesity: an update. Minerva Endocrinol 32: 185-207. [Google Scholar]
  7. Aneja A, El-Atat F, McFarlane SI, Sowers JR (2004) Hypertension and obesity. Recent Prog Horm Res 59: 169-205. [CrossRef] [PubMed]
  8. El-Atat F, Aneja A, McFarlane S, Sowers J (2003) Obesity and hypertension. Endocrinol Metab Clin North Am 32: 823-854. [CrossRef] [PubMed]
  9. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2017) Diabetes statistics. [View]
  10. Centers for Disease Control and Prevention (CDC) (2017) Long-term Trends in Diabetes. [View]
  11. Carrera-Lanestosa A, Moguel-Ordonez Y, Segura-Campos M (2017) Stevia rebaudiana Bertoni: A Natural Alternative for Treating Diseases Associated with Metabolic Syndrome. J Med Food 20: 933-943. [CrossRef] [Google Scholar] [PubMed]
  12. Mishra A, Ahmed K, Froghi S, Dasgupta P (2015) Systematic review of the relationship between artificial sweetener consumption and cancer in humans: analysis of 599,741 participants. Int J Clin Pract 69: 1418-1426. [CrossRef] [Google Scholar] [PubMed]
  13. Antenucci RG, Hayes JE (2015) Nonnutritive sweeteners are not supernormal stimuli. Int J Obes 39: 254-259. [CrossRef] [Google Scholar] [PubMed]
  14. Majchrzak D, Ipsen A, Koenig J (2015) Sucrose-replacement by rebaudioside a in a model beverage. J Food Sci Technol 52: 6031-6036. [CrossRef] [Google Scholar] [PubMed]
  15. Pearlman M, Obert J, Casey L (2017) The Association Between Artificial Sweeteners and Obesity. Curr Gastroenterol Rep 19: 64. [CrossRef] [Google Scholar] [PubMed]
  16. Gardana C, Simonetti P, Canzi E, Zanchi R, Pietta P, et al. (2003) Metabolism of stevioside and rebaudioside A from Stevia rebaudiana extracts by human microflora. J Agric Food Chem 51: 6618-6622. [CrossRef] [Google Scholar] [PubMed]
  17. Choudhary AK, Lee YY (2018) The debate over neurotransmitter interaction in aspartame usage. J Clin Neurosci 56: 7-15. [CrossRef] [Google Scholar] [PubMed]
  18. Goran MI, Plows JF, Ventura EE (2019) Effects of consuming sugars and alternative sweeteners during pregnancy on maternal and child health: evidence for a secondhand sugar effect. Proc Nutr Soc 78: 262-271. [CrossRef] [Google Scholar] [PubMed]
  19. Magnuson BA, Carakostas MC, Moore NH, Poulos SP, Renwick AG, et al. (2016) Biological fate of low-calorie sweeteners. Nutr Rev 74: 670-689. [CrossRef] [Google Scholar] [PubMed]
  20. Kujur RS, Singh V, Ram M, Yadava HN, Singh KK, et al. (2010) Antidiabetic activity and phytochemical screening of crude extract of Stevia rebaudiana in alloxan-induced diabetic rats. Pharmacognosy Res 2: 258-263. [CrossRef] [Google Scholar] [PubMed]
  21. Gregersen S, Jeppesen PB, Holst JJ, Hermansen K (2004) Antihyperglycemic effects of stevioside in type 2 diabetic subjects. Metabolism 53: 73-76. [CrossRef] [Google Scholar] [PubMed]
  22. Jeppesen PB, Gregersen S, Poulsen CR, Hermansen K (2000) Stevioside acts directly on pancreatic beta cells to secrete insulin: actions independent of cyclic adenosine monophosphate and adenosine triphosphate-sensitive K+-channel activity. Metabolism 49: 208-214. [CrossRef] [Google Scholar] [PubMed]
  23. Workgroup on Hypoglycemia ADA (2005) Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 28: 1245-1249. [CrossRef] [Google Scholar] [PubMed]
  24. Momtazi-Borojeni AA, Esmaeili SA, Abdollahi E, Sahebkar A (2017) A Review on the Pharmacology and Toxicology of Steviol Glycosides Extracted from Stevia rebaudiana. Curr Pharm Des 23: 1616-1622. [CrossRef] [Google Scholar] [PubMed]
  25. Wingard RE Jr, Brown JP, Enderlin FE, Dale JA, Hale RL, et al. (1980) Intestinal degradation and absorption of the glycosidic sweeteners stevioside and rebaudioside A. Experientia 36: 519-520. [CrossRef] [Google Scholar] [PubMed]
  26. Geuns JM, Buyse J, Vankeirsbilck A, Temme EH (2007) Metabolism of stevioside by healthy subjects. Exp Biol Med 232: 164-173. [Google Scholar] [PubMed]
  27. Koyama E, Sakai N, Ohori Y, Kitazawa K, Izawa O, et al. (2003) Absorption and metabolism of glycosidic sweeteners of stevia mixture and their aglycone, steviol, in rats and humans. Food Chem Toxicol 41: 875-883. [CrossRef] [Google Scholar] [PubMed]
  28. Philippaert K, Pironet A, Mesuere M, Sones W, Vermeiren L, et al. (2017) Steviol glycosides enhance pancreatic beta-cell function and taste sensation by potentiation of TRPM5 channel activity. Nat Commun 8: 14733. [CrossRef] [Google Scholar]
  29. Huang S, Czech MP (2007) The GLUT4 glucose transporter. Cell Metab 5: 237-252. [CrossRef] [Google Scholar] [PubMed]
  30. Prata C, Zambonin L, Rizzo B, Maraldi T, Angeloni C, et al. (2017) Glycosides from Stevia rebaudiana Bertoni Possess Insulin-Mimetic and Antioxidant Activities in Rat Cardiac Fibroblasts. Oxid Med Cell Longev 2017:3724545. [CrossRef] [Google Scholar] [PubMed]
  31. Chen TH, Chen SC, Chan P, Chu YL, Yang HY, et al. (2005) Mechanism of the hypoglycemic effect of stevioside, a glycoside of Stevia rebaudiana. Planta Med 71: 108-113. [CrossRef] [Google Scholar] [PubMed]
  32. Stolarczyk E (2017) Adipose tissue inflammation in obesity: a metabolic or immune response? Curr Opin Pharmacol 37: 35-40. [CrossRef] [Google Scholar] [PubMed]
  33. Izaola O, de Luis D, Sajoux I, Domingo JC, Vidal M, et al. (2015) Inflammation and obesity (lipoinflammation). Nutr Hosp 31: 2352-2358. [CrossRef] [PubMed]
  34. Wang Z, Xue L, Guo C, Han B, Pan C, et al. (2012) Stevioside ameliorates high-fat diet-induced insulin resistance and adipose tissue inflammation by downregulating the NF-κB pathway. Biochem Biophys Res Commun 417: 1280-1285. [CrossRef] [Google Scholar] [PubMed]
  35. Casas-Grajales S, Ramos-Tovar E, Chavez-Estrada E, et al. Antioxidant and immunomodulatory activity induced by stevioside in liver damage: In vivo, in vitro and in silico assays. Life Sci 224: 187-196. [CrossRef] [Google Scholar] [PubMed]
  36. Ruiz-Ruiz JC, Moguel-Ordonez YB, Segura-Campos MR (2017) Biological activity of Stevia rebaudiana Bertoni and their relationship to health. Crit Rev Food Sci Nutr 57: 2680-2690. [CrossRef] [Google Scholar] [PubMed]
  37. Salehi B, Lopez MD, Martinez-Lopez S, et al. (2019) Stevia rebaudiana Bertoni bioactive effects: From in vivo to clinical trials towards future therapeutic approaches. Phytother Res 33: 2904-2917. [CrossRef] [Google Scholar] [PubMed]
  38. Ramos-Tovar E, Hernández-Aquino E, Casas-Grajales S, Buendia-Montaño LD, Galindo-Gómez S, et al. (2018) Stevia Prevents Acute and Chronic Liver Injury Induced by Carbon Tetrachloride by Blocking Oxidative Stress through Nrf2 Upregulation. Oxid Med Cell Longev 2018: 3823426. [CrossRef] [Google Scholar] [PubMed]
  39. SH KKaK (2017) Nrf2: A key regulator of redox signaling in liver diseases. In: Muriel P, ed. Liver Pathophysiology: Therapies and Antioxidants. Elsevier, Inc 2017:472-479.
  40. Ramos-Tovar E, Flores-Beltran RE, Galindo-Gomez S, Camacho J, Tsutsumi V, et al. (2019) An aqueous extract of Stevia rebaudiana variety Morita II prevents liver damage in a rat model of cirrhosis that mimics the human disease. Ann Hepatol 18: 472-479. [CrossRef] [Google Scholar] [PubMed]
  41. Abo Elnaga N MM, Yousef M, Mohamed H (2015) Effect of stevia sweetener consumption as non-caloric sweetening on body weight gain and biochemical parameters in overweight female rats. Ann Agric Sci 61: 155-163. [CrossRef] [Google Scholar]
  42. Chang JC, Wu MC, Liu IM, Cheng JT (2005) Increase of insulin sensitivity by stevioside in fructose-rich chow-fed rats. Horm Metab Res 37: 610-616. [CrossRef] [Google Scholar] [PubMed]
  43. Wiebe N, Padwal R, Field C, Marks S, Jacobs R, et al. (2011) A systematic review on the effect of sweeteners on glycemic response and clinically relevant outcomes. BMC Med 9: 123. [CrossRef] [Google Scholar] [PubMed]
  44. Anton SD, Martin CK, Han H, Coulon S, Cefalu WT, et al. (2010) Effects of stevia, aspartame, and sucrose on food intake, satiety, and postprandial glucose and insulin levels. Appetite 55: 37-43. [CrossRef] [Google Scholar] [PubMed]
  45. Geeraert B, Crombe F, Hulsmans M, Benhabiles N, Geuns JM, et al. (2010) Stevioside inhibits atherosclerosis by improving insulin signaling and antioxidant defense in obese insulin-resistant mice. Int J Obes (Lond) 34: 569-577. [CrossRef] [Google Scholar] [PubMed]
  46. Chan P, Tomlinson B, Chen YJ, Liu JC, Hsieh MH, et al. (2000) A double-blind placebo-controlled study of the effectiveness and tolerability of oral stevioside in human hypertension. Br J Clin Pharmacol 50: 215-220. [CrossRef] [Google Scholar] [PubMed]
  47. Hsieh MH, Chan P, Sue YM, Liu JC, Liang TH, et al. (2003) Efficacy and tolerability of oral stevioside in patients with mild essential hypertension: a two-year, randomized, placebo-controlled study. Clin Ther 25: 2797-2808. [CrossRef] [Google Scholar] [PubMed]
  48. Lee CN, Wong KL, Liu JC, Chen YJ, Cheng JT, et al. (2001) Inhibitory effect of stevioside on calcium influx to produce antihypertension. Planta Med 67: 796-799. [CrossRef] [Google Scholar] [PubMed]
  49. Maki KC, Curry LL, Carakostas MC, Tarka SM, Reeves MS, et al. (2008) The hemodynamic effects of rebaudioside A in healthy adults with normal and low-normal blood pressure. Food Chem Toxicol 7: 40-46. [CrossRef] [Google Scholar] [PubMed]
  50. Barriocanal LA, Palacios M, Benitez G, Benitez S, Jimenez JT, et al. (2008) Apparent lack of pharmacological effect of steviol glycosides used as sweeteners in humans. A pilot study of repeated exposures in some normotensive and hypotensive individuals and in Type 1 and Type 2 diabetics. Regul Toxicol Pharmacol 51: 37-41. [CrossRef] [Google Scholar] [PubMed]
  51. Awney HA, Massoud MI, El-Maghrabi S (2011) Long-term feeding effects of stevioside sweetener on some toxicological parameters of growing male rats. J Appl Toxicol 31: 431-438. [CrossRef] [Google Scholar] [PubMed]
  52. (FDA) (2018) FaDA. GRAS Notice No. 768 for Stevia Leaf Extracts. Prepared for the Office of Food Additive Safety, Center for Food Safety and Applied nutrition.
  53. Authority EFS (2010) Scientific opinion of the Panel on Food Additives and Nutrient Sources (ANS) on the Safety of Steviol Glycosides for the Proposed Uses as a Food Additive. Journal of the European Food Safety Authority 8: 1537.
  54. WHO (2016) Global Health Observatory Data: Overweight and Obesity. [View]
Best viewed in Mozilla Firefox, Google Chrome, Safari, Above IE 9.0 version
Privacy Policy | Copyright & Permissions
Copyright © 2013-2024 Graphy Publications, All Rights Reserved.